Stella Diagnostics Inc (SLDX)
Stella Diagnostics, Inc. is a common stock listing on OTC Markets under the symbol SLDX. The company is a healthcare diagnostics business focused on developing molecular diagnostic tools and new drug targets for esophageal diseases. Its research centers on the use of targeted mass spectrometry to measure disease progression in tissue from the lower esophagus, with the aim of helping identify patients at higher risk of advancing from disease to precancerous conditions or cancer. The company’s technology is intended to support clinical interpretation for gastroenterologists, surgical oncologists, and pathologists. Formerly known as JMP Properties, Inc., the company adopted the Stella Diagnostics name in April 2021 and is based in Salt Lake City, Utah.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-SLDX
|
—
|
—
|
—
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
1.538 M
|
—
|
—
|
—
|
—
|
—
|
—
|
